BioSig signs share exchange with Streamex; new CEO McPhie, Lekstrom as Chairman

Streamex Corp.

Streamex shareholders initially get 19.9% of BioSig pre-transaction stock; after approval, 75% of fully diluted shares.
Current CEO Anthony Amato resigns; receives $400K severance, full equity vesting; Henry McPhie becomes new CEO.
Board expands to six: four from BioSig (Amato, Baer, Browne, Abelman), two from Streamex (McPhie, Lekstrom as Chairman).
Special Voting Preferred Stock created to grant Exchangeable Shareholders voting rights; issued after shareholder approval.
Strategic advisors Frank Giustra (Wheaton Precious Metals), Mathew August, Mitchell Williams join post-closing.

item 1.01item 3.02item 5.02item 5.03item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anthony Amato

Other Named Officer

STEX · Streamex Corp.

Filed: May 27, 2025 23:59 UTC

In connection with Mr. Amato’s resignation pursuant to the Share Purchase Agreement, the Company and Mr. Amato expect to enter into (i) a First Amendment to the Executive Employment Agreement (the “First Amendment”) and (ii) a letter agreement (the “Right to Place”).

Source: SEC EDGAR

accession 0001641172-25-012363

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.